1
00:00:00,560 --> 00:00:03,280
Speaker 1: We'd like to interview you about how we can make

2
00:00:03,400 --> 00:00:06,600
Speaker 1: shared lunch better. We've got a survey happening right now

3
00:00:06,680 --> 00:00:09,360
Speaker 1: and we'd love your feedback. It just takes a few minutes,

4
00:00:09,560 --> 00:00:11,879
Speaker 1: and if you're a New Zealand resident, you can go

5
00:00:11,920 --> 00:00:15,200
Speaker 1: on the drawer to one of six fifty dollars Shares's gifts.

6
00:00:15,480 --> 00:00:17,280
Speaker 1: The link is in our show notes.

7
00:00:17,440 --> 00:00:24,880
Speaker 2: Right now you're listening to a Chasi's podcast, just getting

8
00:00:24,920 --> 00:00:30,760
Speaker 2: back to manufacturing these pharmaceuticals. Has AI had much of

9
00:00:30,800 --> 00:00:33,720
Speaker 2: a place here in terms of speeding things.

10
00:00:33,600 --> 00:00:37,279
Speaker 3: Up, So this AI kind of in farmer companies and

11
00:00:37,280 --> 00:00:40,360
Speaker 3: in drug discovery. It's been a topic that investors are

12
00:00:40,440 --> 00:00:44,239
Speaker 3: kind of increasingly focused on and increasingly excited about. And

13
00:00:44,280 --> 00:00:47,239
Speaker 3: one of the key kind of themes or takeaways I

14
00:00:47,280 --> 00:00:49,400
Speaker 3: would say that I really noticed when I was in

15
00:00:49,440 --> 00:00:52,479
Speaker 3: the US is just how excited companies are about the

16
00:00:52,600 --> 00:00:55,360
Speaker 3: use of AI and drug discovery. Because we've already talked

17
00:00:55,400 --> 00:00:59,320
Speaker 3: about how time consuming and expensive it is to develop

18
00:00:59,400 --> 00:01:02,720
Speaker 3: new medicine, and what we've seen is that the developments

19
00:01:02,760 --> 00:01:07,600
Speaker 3: in AI mean that you can develop new molecules around

20
00:01:07,760 --> 00:01:10,240
Speaker 3: ten times as fast, or so you can design new

21
00:01:10,240 --> 00:01:13,520
Speaker 3: molecules around ten times as fast. You can run simulations

22
00:01:13,520 --> 00:01:17,280
Speaker 3: on those molecules around one hundred times as fast. And

23
00:01:17,319 --> 00:01:19,760
Speaker 3: then there's this new concept, which I think is pretty interesting.

24
00:01:19,760 --> 00:01:21,759
Speaker 3: You've heard of the concept of a self driving car.

25
00:01:22,080 --> 00:01:25,319
Speaker 3: There's this new concept of a self driving lab. And

26
00:01:25,360 --> 00:01:28,640
Speaker 3: so what this means is that you have AI and

27
00:01:28,680 --> 00:01:31,840
Speaker 3: then you have robotics, and so you use AI and

28
00:01:31,959 --> 00:01:35,080
Speaker 3: robotics together and they drive the cycle of kind of prediction,

29
00:01:35,280 --> 00:01:40,240
Speaker 3: experimentation and analysis, which means that you can iteratively identify

30
00:01:40,319 --> 00:01:43,680
Speaker 3: new compounds which you then run experiments on, which then

31
00:01:43,760 --> 00:01:46,200
Speaker 3: mean that the whole process is much faster and then

32
00:01:46,240 --> 00:01:48,840
Speaker 3: importantly more cost effective for companies.

33
00:01:49,240 --> 00:01:51,800
Speaker 2: Gosh, So do we have any idea how much that

34
00:01:51,800 --> 00:01:54,520
Speaker 2: would speed things up? We talked about ten years before

35
00:01:55,000 --> 00:01:58,280
Speaker 2: being the time that it can take, I think for exclusivity,

36
00:01:58,320 --> 00:02:00,000
Speaker 2: but I think you know, when you've got a meticine

37
00:02:00,560 --> 00:02:02,840
Speaker 2: in the wings, that can take even longer, can't it.

38
00:02:03,040 --> 00:02:06,040
Speaker 3: Yeah, And I think it's probably too early yet to

39
00:02:06,120 --> 00:02:09,240
Speaker 3: put an actual number on how much it could speed

40
00:02:09,320 --> 00:02:11,400
Speaker 3: things up. But I think what we're seeing is more

41
00:02:11,440 --> 00:02:13,639
Speaker 3: and more companies are talking about it, more and more

42
00:02:13,639 --> 00:02:17,080
Speaker 3: companies are using it in their drug discovery process. So

43
00:02:17,200 --> 00:02:19,880
Speaker 3: I think over time we'll be able to get a

44
00:02:19,880 --> 00:02:23,640
Speaker 3: better sense of how much time it actually is taking

45
00:02:23,680 --> 00:02:26,480
Speaker 3: off the drug discovery process. But to the extent that

46
00:02:26,520 --> 00:02:30,760
Speaker 3: it means we can develop medicines that are cheaper, I

47
00:02:30,760 --> 00:02:32,520
Speaker 3: feel like that could only be a good thing given

48
00:02:32,560 --> 00:02:34,960
Speaker 3: the high costs of healthcare that we're seeing around the

49
00:02:34,960 --> 00:02:35,959
Speaker 3: world now.

50
00:02:36,000 --> 00:02:39,799
Speaker 2: Just thinking about investors looking to invest in the sector,

51
00:02:40,440 --> 00:02:43,360
Speaker 2: I mean, there are those direct stocks, they are probably

52
00:02:43,440 --> 00:02:46,320
Speaker 2: quite expensive at the moment for some people. But also

53
00:02:46,520 --> 00:02:49,560
Speaker 2: what about ETFs. I know on cheeseys, for instance, we've

54
00:02:49,639 --> 00:02:53,359
Speaker 2: got about five or at least there's more actually pharmaceutical

55
00:02:53,400 --> 00:02:56,720
Speaker 2: ETFs that people can look to. They are mainly in

56
00:02:56,760 --> 00:02:59,600
Speaker 2: the US. But also I did see that there was

57
00:02:59,760 --> 00:03:05,640
Speaker 2: a couple of applications for more themed weight loss ETFs

58
00:03:05,680 --> 00:03:09,440
Speaker 2: by I think Amplify and round til investments. We're two

59
00:03:09,560 --> 00:03:12,519
Speaker 2: though I don't think they've actually come to fruition yet.

60
00:03:12,800 --> 00:03:15,720
Speaker 3: So I guess when you're thinking about healthcare, healthcare itself

61
00:03:15,880 --> 00:03:19,760
Speaker 3: is super broad, and then within that there's all different

62
00:03:19,840 --> 00:03:24,640
Speaker 3: kinds of companies, so hospitals, medical device companies, companies that

63
00:03:24,720 --> 00:03:27,400
Speaker 3: sell chemicals that are used in farmer companies that sell

64
00:03:27,480 --> 00:03:29,960
Speaker 3: tools that are used in farmer, so all of that

65
00:03:30,080 --> 00:03:32,600
Speaker 3: kind of sets in the broader healthcare space. And I

66
00:03:32,639 --> 00:03:35,200
Speaker 3: think if you're thinking about getting a broad kind of

67
00:03:35,240 --> 00:03:38,600
Speaker 3: ETF exposure, maybe one way to get a sense of

68
00:03:39,120 --> 00:03:41,720
Speaker 3: what could be better is looking back at what's happened

69
00:03:41,720 --> 00:03:44,520
Speaker 3: over time. And if you look back over a significant

70
00:03:44,520 --> 00:03:47,160
Speaker 3: period of time, say twenty years, the S and P

71
00:03:47,400 --> 00:03:50,800
Speaker 3: five hundred Index and the S and P Healthcare Index

72
00:03:51,080 --> 00:03:54,720
Speaker 3: have actually interestingly performed basically neck on neck, so they

73
00:03:54,760 --> 00:03:57,760
Speaker 3: both generated around a ten percent return per year over

74
00:03:57,800 --> 00:04:01,960
Speaker 3: a twenty year time horizon. If you look at farmer itself,

75
00:04:02,280 --> 00:04:06,560
Speaker 3: that generated around half a percent lower return, so around

76
00:04:06,680 --> 00:04:09,800
Speaker 3: nine and a half percent over that twenty year period

77
00:04:09,800 --> 00:04:12,840
Speaker 3: of time. But if you had managed to pick farmer

78
00:04:12,880 --> 00:04:17,359
Speaker 3: winner Novo or farmer winner Eli Lilly over that period

79
00:04:17,400 --> 00:04:20,440
Speaker 3: of time, you would have generated I think from memory

80
00:04:20,480 --> 00:04:23,200
Speaker 3: it's around a sixteen percent return per ANIM and then

81
00:04:23,240 --> 00:04:25,839
Speaker 3: a twenty five percent return per ANIM. Picking a winner

82
00:04:26,240 --> 00:04:28,160
Speaker 3: can be great. But then if you're looking at a

83
00:04:28,200 --> 00:04:32,119
Speaker 3: diversified exposure, as she would suggest that rather than looking

84
00:04:32,200 --> 00:04:36,920
Speaker 3: for a narrow farmer exposure, a broader health care exposure

85
00:04:36,960 --> 00:04:40,000
Speaker 3: would be better. And then I think especially worth keeping

86
00:04:40,040 --> 00:04:45,159
Speaker 3: in mind. With a diversified easier for Farmer, You're likely

87
00:04:45,240 --> 00:04:48,400
Speaker 3: to have a higher exposure to the largest companies and

88
00:04:48,480 --> 00:04:52,000
Speaker 3: they may have a higher proportion of medicines that are

89
00:04:52,000 --> 00:04:55,400
Speaker 3: coming up to that loss of exclusivity and revenue and

90
00:04:55,440 --> 00:04:57,680
Speaker 3: revenue dropping off. So that's a really important thing to

91
00:04:57,760 --> 00:05:01,040
Speaker 3: keep in mind with Farmer itself, is what is that

92
00:05:01,080 --> 00:05:04,800
Speaker 3: loss of exclusivity burden and how does that sit across

93
00:05:04,839 --> 00:05:06,640
Speaker 3: the companies that are in that ETA.

94
00:05:06,760 --> 00:05:10,480
Speaker 2: Investing involves risk you might lose the money you start with.

95
00:05:10,960 --> 00:05:14,760
Speaker 2: We recommend talking to a licensed financial advisor. We also

96
00:05:14,800 --> 00:05:18,679
Speaker 2: recommend reading product disclosure documents before deciding to invest.